superseded: A later claim replaced it: it keeps its end date and a pointer to the claim that replaced it, and is never deleted.
- Valid from
- 2012-09-30
- Valid until
- 2013-03-31
- Published
- 2012-11-06
- Recorded by AsOf
- 2026-11-08
- Checked
- 2026-11-08 · parsed from the SEC filing
- Confidence
- 0.95
- Replaced by
- 4,238,000,000 United States dollar
Sources
Cite this claim
Plain text
AsOf. "Amgen quarterly revenue: 4,319,000,000 United States dollar", as of 2012-09-30 (until 2013-03-31). Claim clm_5BA2730341DC, https://asof.is/claim/clm_5BA2730341DC, accessed 2026-11-08. Source: https://www.sec.gov/Archives/edgar/data/318154/000144530512003469/0001445305-12-003469-index.htm.
APA
AsOf. (2012). Amgen quarterly revenue: 4,319,000,000 United States dollar (as of 2012-09-30 (until 2013-03-31)) [Record clm_5BA2730341DC]. Retrieved November 8, 2026, from https://asof.is/claim/clm_5BA2730341DC (source: https://www.sec.gov/Archives/edgar/data/318154/000144530512003469/0001445305-12-003469-index.htm)
BibTeX
@misc{asof_clm_5BA2730341DC,
author = {AsOf},
title = {Amgen quarterly revenue: 4,319,000,000 United States dollar},
year = {2012},
howpublished = {\url{https://asof.is/claim/clm_5BA2730341DC}},
note = {Claim clm\_5BA2730341DC, as of 2012-09-30 (until 2013-03-31); source: https://www.sec.gov/Archives/edgar/data/318154/000144530512003469/0001445305-12-003469-index.htm},
urldate = {2026-11-08}
}Supersedes
On the record
/claim/clm_5BA2730341DC.md/v1/claims/clm_5BA2730341DCsubmit a correction